Literature DB >> 7698155

Washout and redistribution between immediate and two-hour myocardial images using technetium-99m sestamibi.

W S Richter1, M Cordes, D Calder, H Eichstaedt, R Felix.   

Abstract

The aim of this study was to assess whether a clinically relevant change in myocardial sestamibi activity could be documented within the first 120 min following injection (p.i.). In 17 patients planar anterior imaging of the heart was performed 5 min and 120 min p.i. During this time interval, mean decay-corrected myocardial activity declined to 77.9% +/- 9.7% after stress and to 85.7% +/- 7.9% after injection at rest (P < 0.05). In 19 patients with angiographically documented coronary artery disease, single-photon emission tomography was performed 5 min and 120 min after injection at maximum stress. For analysis, sestamibi activity was scored semiquantitatively in six left ventricular segments. Furthermore, sestamibi uptake was assessed quantitatively using a circumferential profile method. In 35 of 114 segments the score improved within 120 min p.i. (early fill-in); in these segments relative sestamibi activity rose from 69.9% +/- 22.5% to 74.5% +/- 20.8% (P < 0.01). In five patients this early fill-in was the only sign of exercise-induced hypoperfusion. In 7 of 114 segments the score deteriorated 120 min p.i. (early tracer washout); in these segments relative sestamibi activity declined from 85.6% +/- 9.9% to 80.1% +/- 10.7% (P < 0.02). In three of four patients with early tracer washout the corresponding coronary artery was significantly narrowed. In conclusion, a global myocardial sestamibi washout was registered within the first 120 min after injection. A fill-in of initial defects as well as an early tracer loss could be detected in a relevant number of patients with chronic coronary artery disease during the first 2 h p.i.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7698155     DOI: 10.1007/bf00997247

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  18 in total

1.  Effective dose from radiopharmaceuticals.

Authors:  L Johansson; S Mattsson; B Nosslin; S Leide-Svegborn
Journal:  Eur J Nucl Med       Date:  1992

Review 2.  Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium.

Authors:  V Dilsizian; R O Bonow
Journal:  Circulation       Date:  1993-01       Impact factor: 29.690

3.  Resting technetium-99m methoxyisobutylisonitrile cardiac imaging in chronic coronary artery disease: comparison with rest-redistribution thallium-201 scintigraphy.

Authors:  A Cuocolo; S Maurea; L Pace; E Nicolai; A Nappi; M Imbriaco; B Trimarco; M Salvatore
Journal:  Eur J Nucl Med       Date:  1993-12

4.  [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].

Authors:  C A Schneider; E Voth; P Theissen; K Wienhard; R Wagner; F M Baer; U Sechtem; H Schicha
Journal:  Z Kardiol       Date:  1994-02

5.  Myocardial kinetics of Tc-MIBI in canine myocardium after dipyridamole.

Authors:  D K Glover; R D Okada
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

6.  Reverse and pseudo redistribution of thallium-201 in healed myocardial infarction and normal and negative thallium-201 washout in ischemia due to background oversubtraction.

Authors:  J L Lear; U Raff; R Jain
Journal:  Am J Cardiol       Date:  1988-09-15       Impact factor: 2.778

7.  Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.

Authors:  V Dilsizian; J A Arrighi; J G Diodati; A A Quyyumi; K Alavi; S L Bacharach; J A Marin-Neto; P T Katsiyiannis; R O Bonow
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

8.  Fast washout of thallium-201 from area of myocardial infarction: possible artifact of background subtraction.

Authors:  K A Brown; L Benoit; J P Clements; F J Wackers
Journal:  J Nucl Med       Date:  1987-06       Impact factor: 10.057

9.  The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability.

Authors:  P Marzullo; G Sambuceti; O Parodi
Journal:  J Nucl Med       Date:  1992-11       Impact factor: 10.057

10.  Clinical comparison between thallium-201 and Tc-99m-methoxy isobutyl isonitrile (hexamibi) myocardial perfusion imaging for detection of coronary artery disease.

Authors:  R Taillefer; R Lambert; G Dupras; J Grégoire; J Léveillé; R Essiambre; D C Phaneuf
Journal:  Eur J Nucl Med       Date:  1989
View more
  2 in total

1.  FMTVDM-TFM©℗: True quantification requires standardization of the tool being used to measure, with a known, unchanging standard to produce accurate, consistent and reproducible quantified measurements.

Authors:  Richard M Fleming; Matthew R Fleming; Andrew McKusick; Tapan Chaudhuri
Journal:  J Nucl Cardiol       Date:  2018-06-19       Impact factor: 5.952

2.  Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease.

Authors:  C Rossetti; C Landoni; G Lucignani; G Huang; A L Bartorelli; M D Guazzi; A Margonato; S Chierchia; L Galli; A Savi
Journal:  Eur J Nucl Med       Date:  1995-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.